These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 487086)

  • 1. Immune lesions of central noradrenergic neurons produced by antibodies to dopamine-beta-hydroxylase.
    Costa M; Geffen LB; Rush RA; Bridges D; Blessing WW; Heath JW
    Brain Res; 1979 Sep; 173(1):65-78. PubMed ID: 487086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific uptake and retrograde flow of antibody to dopamine-beta-hydroxylase by central nervous system noradrenergic neurons in vivo.
    Silver MA; Jacobowitz DM
    Brain Res; 1979 May; 167(1):65-75. PubMed ID: 88246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker.
    Swanson LW; Hartman BK
    J Comp Neurol; 1975 Oct; 163(4):467-505. PubMed ID: 1100685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune lesions of noradrenergic neurones in rat central nervous system produced by antibodies to dopamine-beta-hydroxylase.
    Blessing WW; Costa M; Geffen LB; Rush RA; Fink G
    Nature; 1977 May; 267(5609):368-9. PubMed ID: 865635
    [No Abstract]   [Full Text] [Related]  

  • 5. Involvement of complement in degeneration of sympathetic nerves after administration of antiserum to dopamine beta-hydroxylase.
    Furness JB; Lewis SY; Rush R; Costa M; Geffen LB
    Brain Res; 1977 Nov; 136(1):67-75. PubMed ID: 589447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origins of spinal noradrenergic pathways demonstrated by retrograde transport of antibody to dopamine-beta-hydroxylase.
    Westlund KN; Bowker RM; Ziegler MG; Coulter JD
    Neurosci Lett; 1981 Sep; 25(3):243-9. PubMed ID: 6170028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional development of norepinephrine, dopamine-beta-hydroxylase and tyrosine hydroxylase in the rat brain subsequent to neonatal treatment with subcutaneous 6-hydroxydopamine.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Apr; 166(2):293-308. PubMed ID: 34468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.
    Fritschy JM; Grzanna R
    Neuroscience; 1989; 30(1):181-97. PubMed ID: 2747911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic projections to the spinal cord of the rat.
    Westlund KN; Bowker RM; Ziegler MG; Coulter JD
    Brain Res; 1983 Mar; 263(1):15-31. PubMed ID: 6839168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origins and terminations of descending noradrenergic projections to the spinal cord of monkey.
    Westlund KN; Bowker RM; Ziegler MG; Coulter JD
    Brain Res; 1984 Jan; 292(1):1-16. PubMed ID: 6365245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic system in the chicken brain: immunocytochemical study with antibodies to noradrenaline and dopamine-beta-hydroxylase.
    Moons L; D'Hondt E; Pijcke K; Vandesande F
    J Comp Neurol; 1995 Sep; 360(2):331-48. PubMed ID: 8522651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective lesion of the developing central noradrenergic system: short- and long-term effects and reinnervation by noradrenergic-rich tissue grafts.
    Coradazzi M; Gulino R; Garozzo S; Leanza G
    J Neurochem; 2010 Aug; 114(3):761-71. PubMed ID: 20477936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat medulla oblongata. II. Dopaminergic, noradrenergic (A1 and A2) and adrenergic neurons, nerve fibers, and presumptive terminal processes.
    Kalia M; Fuxe K; Goldstein M
    J Comp Neurol; 1985 Mar; 233(3):308-32. PubMed ID: 2858497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-dopaminergic catecholaminergic neurons of mesencephalic and medullary nuclei contain different levels of dopamine.
    Alonso G; Brun O; Ridet JL; Geffard M; Chauvet N
    J Chem Neuroanat; 1995 Oct; 9(3):195-205. PubMed ID: 8588834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The response of noradrenergic axons to systemically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine-beta-hydroxylase.
    Fritschy JM; Geffard M; Grzanna R
    J Chem Neuroanat; 1990; 3(4):309-21. PubMed ID: 2204356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible changes in the accumulation and activities of tyrosine hydroxylase and dopamine-beta-hydroxylase in neurons of nucleus locus coeruleus during the retrograde reaction.
    Ross RA; Joh TH; Reis DJ
    Brain Res; 1975 Jul; 92(1):57-72. PubMed ID: 240484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrograde transport of dopamine beta-hydroxylase antibodies in sympathetic neurons: effects of drugs modifying noradrenergic transmission.
    Lees GJ; Horsburgh RJ
    Brain Res; 1984 Jun; 301(2):281-6. PubMed ID: 6203610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Projections of ventromedial hypothalamic neurons to the midbrain central gray: an ultrastructural study.
    Chung SK; Pfaff DW; Cohen RS
    Neuroscience; 1990; 38(2):395-407. PubMed ID: 2175855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain.
    Fritschy JM; Grzanna R
    J Comp Neurol; 1992 Jul; 321(3):421-41. PubMed ID: 1506478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of dopamine -hydroxylase as a marker for the central noradrenergic nervous system in rat brain.
    Hartman BK; Zide D; Udenfriend S
    Proc Natl Acad Sci U S A; 1972 Sep; 69(9):2722-6. PubMed ID: 4560699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.